12,562 press releases in English indexed under finance.
STEINHAUSEN, Switzerland, Oct. 12, 2026 -- Transocean Ltd. (NYSE: RIG) (“Transocean”) announced today that it will report earnings for the third quarter 2026 and issue a fleet status report on Monday, November 2, 2026, after the close of trading on the New York Stock Exchange.
HOUSTON, Oct. 12, 2026 -- Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific”) today announced that it will release its third quarter 2026 results after the New York Stock Exchange closes on Tuesday, November 3, 2026. This release will be followed by a conference call for investors on Wednesday, November 4, 2026, at 9:00 a.m. Central Time (10:00 a.m. Eastern). The full text of the release will be available on Par Pacific’s website at http://www.parpacific.com.
GROSSE POINTE FARMS, Mich., Oct. 12, 2026 -- Saga Communications, Inc. (Nasdaq: SGA) announced today that it will release its 3rd Quarter 2026 Earnings results at 9:00 a.m. EST on Thursday, November 12, 2026. The company will be holding a conference call on the same date at 11:00 a.m. EST. The dial-in numbers are as follows:
CANTON, Mass., Oct. 12, 2026 -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced the publication of previously released results from PREPARE1, a prospective, multicenter, randomized controlled trial (RCT) evaluating PuraPly®AM (PCMP) plus standard of care (SoC) compared to SoC alone in hard-to-heal diabetic foot ulcers (DFUs). The trial achieved its primary endpoint, and the results published in the Journal of Wound Care demonstrate statistically significant improvements in wound closure at 12 weeks among patients treated with PuraPly®AM plus SoC, providing clinical evidence supporting the use of PuraPly®AM in one of the most costly and difficult-to-treat chronic wound populations.
NASHVILLE, Tenn., Oct. 12, 2026 -- Healthcare Realty Trust Incorporated (NYSE: HR) today released its eighth annual Corporate Responsibility Report, highlighting the Company’s 2025 environmental, social, and governance (ESG) initiatives and accomplishments. The report outlines the Company’s progress toward its stated key performance indicators, environmental performance, and disclosures that align with the Task Force on Climate-Related Financial Disclosures (TCFD) and the Sustainability Accounting Standards Board (SASB).
SAN JOSE, Calif., Oct. 12, 2026 -- PROCEPT BioRobotics Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the third quarter of 2026 after market close on Wednesday, November 4, 2026. The Company’s management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.
SOUTH SAN FRANCISCO, Calif., Oct. 12, 2026 -- BridgeBio Oncology Therapeutics, Inc., or BBOT (NASDAQ: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced it awarded an inducement grant on October 10, 2026, under BBOT’s 2025 Inducement Plan as a material inducement to the employment of one individual hired by BBOT in September 2026.
New York, New York--(October 12, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Tigo Energy, Inc. ("Tigo Energy" or the "Company") (NASDAQ: TYGO) on behalf of investors that purchased or otherwise acquired Tigo Energy securities between February 24, 2026 and August 4, 2026 (the "Class Period").CLICK HERE TO JOIN THE CASEIf you are an investor in Tigo Energy and have suffered losses, you may CLICK HERE to contact us. You may also...
Kaplan Fox announces a securities class action against The Ensign Group (NASDAQ: ENSG) for investors from Feb. 10, 2022 to June 18, 2026.
Earnings Call Set for Friday, November 6, 2026 at 8:00 a.m. ET Earnings Call Set for Friday, November 6, 2026 at 8:00 a.m. ET
A securities class action alleges AppLovin management publicly dismissed a "disconnect between market sentiment and the reality of our business" while the pace of meaningful AI model improvement was allegedly already slowing, and APP shareholders who believed that message watched the stock slide A securities class action alleges AppLovin management publicly dismissed a "disconnect between market sentiment and the reality of our business" while the pace of meaningful AI model improvement was allegedly already slowing, and APP shareholders who believed that message watched the stock slide
Promise versus reality: AST SpaceMobile told shareholders a financing had been completed with "minimal dilution," yet the complaint alleges that $3.0 billion of convertible notes followed in nine months and ASTS stock price faltered as a result Promise versus reality: AST SpaceMobile told shareholders a financing had been completed with "minimal dilution," yet the complaint alleges that $3.0 billion of convertible notes followed in nine months and ASTS stock price faltered as a result